Sustained antipsychotic effect of metacognitive training in psychosis: a randomized-controlled study.

Détails

Ressource 1Demande d'une copie Sous embargo indéterminé.
Etat: Public
Version: de l'auteur
ID Serval
serval:BIB_A6C4B2F7836F
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Sustained antipsychotic effect of metacognitive training in psychosis: a randomized-controlled study.
Périodique
European Psychiatry
Auteur(s)
Favrod J., Rexhaj S., Bardy S., Ferrari P., Hayoz C., Moritz S., Conus P., Bonsack C.
ISSN
1778-3585 (Electronic)
ISSN-L
0924-9338
Statut éditorial
Publié
Date de publication
2014
Peer-reviewed
Oui
Volume
29
Numéro
5
Pages
275-281
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Résumé
Persistent psychotic symptoms represent a major challenge for psychiatric care. Basic research has shown that psychotic symptoms are associated with cognitive biases. Metacognitive training (MCT) aims at helping patients to become aware of these biases and to improve problem-solving. Fifty-two participants fulfilling diagnostic criteria of schizophrenia or schizoaffective disorders and persistent delusions and stabilized antipsychotic medication were enrolled in this study. Following baseline assessment patients were randomized either to treatment as usual (TAU) conditions or TAU+MCT. The intervention consisted of eight weekly 1-hour sessions (maximum: 8 hours). Participants were assessed at 8 weeks and 6-months later by blind assessors. Participants were assessed with the Psychotic Symptoms Rating Scales (PSYRATS) and the positive subscale of the PANSS. Between-group differences in post- and pre-test values were significant at a medium effect size in favor of the MCT for the PSYRATS delusion scale and the positive scale of the PANSS both at post and follow-up. The results of this study indicate that MCT training has a surplus antipsychotic effect for patients suffering from schizophrenia-related disorders who demonstrate only a partial response to antipsychotic treatment and that the effect of the intervention persists for at least 6 months after the intervention.
Pubmed
Web of science
Création de la notice
07/11/2013 15:16
Dernière modification de la notice
20/08/2019 16:11
Données d'usage